SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 535 filers reported holding SEAGEN INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,645,734 | +15.3% | 252,867 | +4.6% | 0.02% | +21.1% |
| Q2 2023 | $46,546,836 | +136.0% | 241,852 | +148.3% | 0.02% | +137.5% |
| Q1 2023 | $19,720,983 | +107.0% | 97,402 | +31.4% | 0.01% | +100.0% |
| Q4 2022 | $9,528,759 | -5.9% | 74,148 | +0.2% | 0.00% | -20.0% |
| Q3 2022 | $10,125,000 | -46.0% | 73,995 | -30.2% | 0.01% | -44.4% |
| Q2 2022 | $18,760,000 | -21.1% | 106,022 | -35.8% | 0.01% | 0.0% |
| Q1 2022 | $23,788,000 | -20.2% | 165,137 | -14.3% | 0.01% | -18.2% |
| Q4 2021 | $29,793,000 | +43.4% | 192,711 | +57.5% | 0.01% | +37.5% |
| Q3 2021 | $20,771,000 | +74.6% | 122,324 | +62.3% | 0.01% | +60.0% |
| Q2 2021 | $11,896,000 | +3.9% | 75,348 | -8.6% | 0.01% | 0.0% |
| Q1 2021 | $11,445,000 | -13.1% | 82,420 | +9.6% | 0.01% | -16.7% |
| Q4 2020 | $13,174,000 | – | 75,218 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |